DAVID L. PEARLE, M.D. PROFESSOR OF MEDICINE Chest Pain One of the most common complaints of patients being seen in the Emergency Department 5 million patients/year seen with…

1. Srdan (Serge) Verstovsek M.D., Ph.D. Professor of Medicine Department of Leukemia University of Texas MD Anderson Cancer Center Houston, Texas, USA ASH 2012: New JAK Inhibitors…

1. What is NEW in T2DM? Anil BhansaliDepartment of Endocrinology PGIMER, Chandigarh 2. Recents in T2DM Prevalence Pathogenesis Diagnosis Treatment -Targets -…

1. Raj Kiran Medapalli, MD, MPH. Nephrology Fellow October 1st, 2008 Mount Sinai School of Medicine Division of Nephrology Journal Club 2. Preeclampsia and the Risk of ESRD…

1. ToluwalaseAjayi, MD Palliative Care Fellow San Diego Hospice and Institutive of Palliative Care 2. Objectives Expanding our patient base can broaden the spectrum of…

1. Interim Analysis (IA) Results of COU-AA-302, a Randomized, Phase 3 Study of Abiraterone Acetate(AA) in Chemotherapy-Naïve Patients (pts) With Metastatic Castration-Resistant…

1. Interim Analysis (IA) Results of COU-AA-302, a Randomized, Phase 3 Study of Abiraterone Acetate(AA) in Chemotherapy-Naïve Patients (pts) With Metastatic Castration-Resistant…

1. Nicotine safety in the context of e-cigarette use and tobacco dependenceJacques Le Houezec Consultant in Public Health, Tobacco Dependence Amzer Glas, Rennes & Special…

1. Medication Adherence and Compliance – the Pharmacist’s RoleBaeteena M. Black, D.Ph. Executive Director Tennessee Pharmacists Association October 23, 2010 2. Acknowledgments…

1. The Current State of Pharmacogenomics Marti Larriva PharmD Candidate, Class of 2014 University of Arizona 2. Objectives Discuss background and relevance of pharmacogenomics…